Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2006;48:23-24
Published online before print May 30, 2006, doi: 10.1161/01.HYP.0000226914.44904.ca
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
48/1/23    most recent
01.HYP.0000226914.44904.cav1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flynn, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flynn, J. T.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Clinical Studies
Right arrow Doppler ultrasound, Transcranial Doppler etc.
Right arrow Mechanism of atherosclerosis/growth factors
Right arrowRelated Article

(Hypertension. 2006;48:23.)
© 2006 American Heart Association, Inc.


Editorial Commentary

What Is the Significance of Increased Carotid Intima Media Thickness in Hypertensive Adolescents?

Joseph T. Flynn

From the Pediatric Hypertension Program, Children’s Hospital at Montefiore and Albert Einstein College of Medicine, Bronx, NY.

Correspondence to Division of Pediatric Nephrology, Montefiore Medical Center, 111 East 210th St, Bronx, NY 10467. E-mail jflynn@montefiore.org


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Fortunately, common cardiovascular sequelae of long-standing hypertension in adults, such as myocardial infarction and stroke, are not seen in hypertensive children and adolescents. However, it is well established that persistent blood pressure elevation in the young can produce other target-organ effects. Chief among these are left ventricular hypertrophy (LVH), which may be present in ≤30% of children at the time of diagnosis of hypertension,1 and abnormal left ventricular geometry, which is typically seen in those with more severe blood pressure elevation. LVH can be seen even in adolescents with even mild blood pressure elevation and is probably the most readily assessed target-organ effect of hypertension in the young because of the wide availability of echocardiography. Its importance as a cardiovascular risk factor was recently highlighted by the National High Blood Pressure Education Program (NHBPEP) Working Group on High Blood Pressure in Children and Adolescents, which recommended that echocardiograms be obtained as part of the initial evaluation of children and adolescents with confirmed hypertension.2 It was further recommended that if LVH is found, the antihypertensive therapy should be intensified.

Other consequences of hypertension almost certainly develop in young hypertensive subjects but are more difficult to demonstrate. These include renal damage, hypertensive retinopathy, and cognitive impairment. Hypertensive renal damage probably first manifests as microalbuminuria and later progresses to end-stage renal disease; indeed, hypertension is one of the leading causes of chronic kidney disease in adults.3 In children, however, the incidence of renal damage from isolated hypertension has not been established, and although . . . [Full Text of this Article]


Related Article:

Effects of Childhood Primary Hypertension on Carotid Intima Media Thickness: A Matched Controlled Study
Marc B. Lande, Nancy L. Carson, Jason Roy, and Cecilia C. Meagher
Hypertension 2006 48: 40-44. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
J. T. Flynn
Hypertension in the young: epidemiology, sequelae and therapy
Nephrol. Dial. Transplant., February 1, 2009; 24(2): 370 - 375.
[Full Text] [PDF]


Home page
Vasc MedHome page
T. W. Rooke
Controversies in vascular screening art versus science
Vascular Medicine, August 1, 2007; 12(3): 235 - 242.
[Abstract] [PDF]